26256 Federal Register / Vol. 75, No. 90 / Tuesday, May 11, 2010 / Notices 

A. Federal Reserve Bank of 

Minneapolis (Jacqueline G. King, 

Community Affairs Officer) 90 

Hennepin Avenue, Minneapolis, 

Minnesota 55480–0291: 

1. Joyce J. Eickhoff Revocable Trust, 

and Joyce J. Eckhoff, Trustee, both of 

Adrian, Minnesota; to acquire voting 

shares of Adrian Building Corporation, 

and thereby indirectly acquire voting 

shares of Adrian State Bank, both of 

Adrian, Minnesota. 

B. Federal Reserve Bank of San 

Francisco (Kenneth Binning, Vice 

President, Applications and 

Enforcement) 101 Market Street, San 

Francisco, California 94105–1579: 

1. Thomas H. Lee Equity Fund VI, 

L.P.; Thomas H. Lee Parallel Fund VI, 

L.P.; Thomas H. Lee Parallel (DT) Fund 

VI, L.P.; and THL Sterling Equity 

Investors, L.P., all of Boston, 

Massachusetts; to acquire voting shares 

of Sterling Financial Corporation, and 

thereby indirectly acquire voting shares 

of Sterling Savings Bank, both of 

Spokane, Washington, and Golf Savings 

Bank, Mountlake Terrace, Washington. 

Board of Governors of the Federal Reserve 

System, May 6, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–11113 Filed 5–10–10; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–10–0004] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Disease Surveillance 

Program II. Disease Summaries (OMB 

No. 0920–0004 Exp. 5/31/2010)— 

Extension—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID) (proposed), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Surveillance of the incidence and 

distribution of disease has been an 

important function of the U.S. Public 

Health Service (PHS) since 1878. 

Through the years, PHS/CDC has 

formulated practical methods of disease 

control through field investigations. The 

CDC National Disease Surveillance 

Program is based on the premise that 

diseases cannot be diagnosed, 

prevented, or controlled until existing 

knowledge is expanded and new ideas 

developed and implemented. Over the 

years, the mandate of CDC has 

broadened to include preventive health 

activities and the surveillance systems 

maintained have expanded. CDC and 

the Council of State and Territorial 

Epidemiologists (CSTE) collect data on 

disease and preventable conditions in 

accordance with jointly approved plans. 

Changes in the surveillance program 

and in reporting methods are effected in 

the same manner. At the onset of this 

surveillance program in 1968, the CSTE 

and CDC decided on which diseases 

warranted surveillance. These diseases 

are reviewed and revised based on 

variations in the public’s health. 

Surveillance forms are distributed to the 

State and local health departments who 

voluntarily submit these reports to CDC 

at variable frequencies, either weekly or 

monthly. CDC then calculates and 

publishes weekly statistics via the 

Morbidity and Mortality Weekly Report 

(MMWR), providing the states with 

timely aggregates of their submissions. 

The following diseases/conditions are 

included in this program: Diarrheal 

disease surveillance (includes 

campylobacter, salmonella, and 

shigella), foodborne outbreaks, arboviral 

surveillance (ArboNet), Influenza virus, 

including the annual survey and 

influenza-like illness, Respiratory and 

Enterovirus surveillance, rabies, 

waterborne diseases, cholera and other 

vibrio illnesses, Listeria, Calcinet, 

Harmful Algal Bloom-related Infectious 

Surveillance System (HABISS) data 

entry form, and the HABISS monthly 

reporting form. These data are essential 

on the local, state, and Federal levels for 

measuring trends in diseases, evaluating 

the effectiveness of current prevention 

strategies, and determining the need for 

modifying current prevention measures. 

This request is for extension of the 

currently approved data collection for 

three years. Because of the distinct 

nature of each of the diseases, the 

number of cases reported annually is 

different for each. There is no cost to 

respondents other than their time. The 

estimated annualized burden hours are 

22,356. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Respondents 

state epidemiologists Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) Form 

Diarrheal Disease Surveillance: Campylobacter (electronic) .......................................... 53 52 3/60 

Diarrheal Disease Surveillance: Salmonella (electronic) ................................................ 53 52 3/60 

Diarrheal Disease Surveillance: Shigella (electronic) ..................................................... 53 52 3/60 

Foodborne Outbreak Form .............................................................................................. 54 31.5 20/60 

Arboviral Surveillance (ArboNet) ..................................................................................... 57 1421 4/60 

—Influenza virus (fax, Oct–May) .............................................................................. 8 33 10/60 

—Influenza virus (fax, year round) ........................................................................... 15 52 10/60 

Influenza virus (Internet; Oct–May) ................................................................................. 13 33 10/60

Influenza virus (Internet; year round) .............................................................................. 24 52 10/60

—Influenza virus (electronic, Oct–May) ................................................................... 9 33 5/60 

—Influenza virus (electronic, year round) ................................................................ 14 52 5/60 

Influenza Annual Survey .................................................................................................. 83 1 15/60 

Influenza-like Illness (Oct–May) ...................................................................................... 824 33 15/60 

Influenza-like Illness (year round) ................................................................................... 496 52 15/60 

Monthly Respiratory & Enterovirus Surveillance Report:—Excel format (electronic) ..... 25 12 15/60 


emcdonald on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 90 / Tuesday, May 11, 2010 / Notices 26257 

ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued 

Respondents 

state epidemiologists Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) Form 

National Respiratory & Enteric Virus Surveillance System (NREVSS) .......................... 90 52 10/60 

Rabies (electronic) ........................................................................................................... 50 12 8/60 

Rabies (paper) ................................................................................................................. 3 12 15/60 

Waterborne Diseases Outbreak Form ............................................................................. 57 1 20/60 

Cholera and other Vibrio illnesses .................................................................................. 450 1 20/60 

Outbreak Report of Suspected Viral Gastroenteritis (Clicivirus surveillance) ................. 20 5 5/60 

Listeria Case Form .......................................................................................................... 53 1 30/60 

HABISS data entry form .................................................................................................. 10 12 8

HABISS monthly reporting form ...................................................................................... 10 12 30/60 

Dated: May 5, 2010. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–11178 Filed 5–10–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day-10–09BQ] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Examining In-vehicle Exposures to 

Air Pollutants and Corresponding 

Health Outcomes of Commuters— 

New—National Center for 

Environmental Health, (NCEH) and 

Agency for Toxic Substances and 

Disease Registry (ATSDR), Centers for 

Disease Control and Prevention, (CDC). 

Background and Brief Description 

Numerous studies have found 

associations between ambient fine 

particulate matter (PM2.5) and adverse 

cardiovascular outcomes. Several recent 

epidemiologic studies suggest that 

vehicle-related emissions, in particular, 

may be linked to many of the these 

adverse effects and that specific subpopulations may be more susceptible to 

health risks due to their enhanced 

exposures to vehicle-related PM2.5

sources. Commuters are a potentially 

susceptible, yet poorly characterized, 

sub-population. Importantly, recent 

epidemiologic studies indicate that 

specific sub-groups, including those 

with asthma, may be at risk to cardio 

respiratory health effects due to their 

pre-existing health condition. A more 

complete understanding of in-vehicle 

exposures for the commuter population, 

especially those with asthma, is 

therefore becoming increasingly 

necessary as commuting durations and 

roadway congestion have steadily 

increased throughout the U.S. during 

the last 20 years. The National Center 

for Environmental Health (NCEH), 

Centers for Disease Control and 

Prevention (CDC) will conduct this 

study to characterize in-vehicle 

exposures to traffic-related air 

pollutants among commuters, with and 

without asthma, and any health impacts 

that these exposures may have on the 

commuter. 

A total of 40 participants (20 adults 

with physician-diagnosed asthma and 

20 healthy adults) living in the Atlanta 

metro area will be recruited for 

participation in this study. Participants 

will be excluded if they meet specific 

criteria including: ever being diagnosed 

with severe asthma, ever suffering a 

myocardial infarction, smoking tobacco 

products, or ever being diagnosed with 

a pulmonary disease such as 

emphysema, chronic obstructive 

pulmonary disorder (COPD), or any type 

of lung cancer, will be excluded. 

Prior to their scheduled commute, 

participants will complete a one-time 

baseline questionnaire to assess medical 

history and general exposures. 

Additionally, a short symptom diary 

recording any respiratory symptoms 

will be completed by the participant 

prior to the commute and health 

measurements for lung function, lung 

inflammatory markers, heart rate, and 

biomarkers of systemic inflammation 

will be conducted by a trained field 

technician. In-vehicle exposures to 

particulate matter and other air 

pollutants will then be measured for all 

participants during their commute. 

After the commute, the symptom diary 

and health measurements will be 

conducted again to assess any potential 

changes in respiratory and 

cardiovascular health effects. Each 

participant will conduct the commute 

two times during the study year. The 

information learned from the health 

measurements and diary entries before 

and after the commute will be important 

in better understanding the potential 

acute health impacts associated with 

exposures to in-vehicle traffic pollutants 

and respiratory and cardiovascular 

health, and whether urban commuters— 

especially those with asthma—should 

be viewed as a susceptible subpopulation given their enhanced 

exposures to PM2.5 and gas-phase 

pollutants. 

There is no cost to participants other 

than their time. The estimated annual 

burden hours are 180 hours. 


emcdonald on DSK2BSOYB1PROD with NOTICES